Tcr2 Therapeutics Inc.

NORTHERN TRUST CORP

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

93,933

Value ($000)

141

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	141	0.0%	93,933	3/31/2023
2022 Q4	2/13/2023	86	0.0%	86,492	12/31/2022
2022 Q3	11/14/2022	161	0.0%	89,813	9/30/2022
2022 Q2	8/12/2022	249	0.0%	85,937	6/30/2022
2022 Q1	5/13/2022	793	0.0%	287,251	3/31/2022
2021 Q4	2/8/2022	1,464	0.0%	314,171	12/31/2021
2021 Q3	11/15/2021	2,760	0.0%	324,310	9/30/2021
2021 Q2	8/13/2021	5,435	0.0%	331,163	6/30/2021
2021 Q1	5/12/2021	7,274	0.0%	329,425	3/31/2021
2020 Q4	2/11/2021	10,404	0.0%	336,390	12/31/2020
2020 Q3	11/16/2020	6,975	0.0%	343,287	9/30/2020
2020 Q2	8/14/2020	3,917	0.0%	255,004	6/30/2020
2020 Q1	5/14/2020	1,191	0.0%	153,853	3/31/2020
2019 Q4	2/14/2020	2,107	0.0%	147,581	12/31/2019